Evaluating stability and bioactivity of Rehmannia-derived nanovesicles during storage.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 08 2024
Historique:
received: 28 03 2024
accepted: 14 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 28 8 2024
Statut: epublish

Résumé

Plant-derived nanovesicles (PDNVs) have garnered growing attention in the biomedical field owing to their abundance in plant-derived ribonucleic acids (RNA), proteins, lipids and metabolites. The question about the preservation of PDNVs is a crucial and unavoidable concern in both experiments' settings and their potential clinical application. The objective of this research was to examine the impact of varying storage temperatures on the stability and bioactivity of Rehmannia-derived nanovesicles (RDNVs). The results showed that RDNVs aggregated after 2 weeks of storage period at 4 °C, and the particle size of some RDNVs gradually increased with time, along with the increase of solution potential. After 2 months of storage, all RDNVs exhibited varying levels of aggregation irrespective of storage temperature. The bioactivities of nanovesicles under different temperature storage conditions revealed a gradual decline in cell proliferation inhibition bioactivity over time, significantly lower than that of freshly prepared RDNVs. In contrast, the preservation of anti-migratory activity in RDNVs was found to be more effective when subjected to rapid freezing in liquid nitrogen followed by storage at - 80 °C, as opposed to direct storage at - 80 °C. These findings suggest that temperature alone may not be sufficient in safeguarding the activity and stability of RDNVs, highlighting the necessity for the development of novel protective agents for PDNVs.

Identifiants

pubmed: 39198513
doi: 10.1038/s41598-024-70334-5
pii: 10.1038/s41598-024-70334-5
doi:

Substances chimiques

Plant Extracts 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19966

Subventions

Organisme : the Startup Fund for scientific research, Fujian Medical University
ID : 2023QH2014
Organisme : Special Project of Central Government for Local Science and Technology Development of Fujian Province
ID : 2023L3011
Organisme : National Natural Science Foundation of China
ID : 82173180
Organisme : National Natural Science Foundation of China
ID : 82272868

Informations de copyright

© 2024. The Author(s).

Références

Chen, X. et al. Plant-derived nanovesicles: Harnessing nature’s power for tissue protection and repair. J. Nanobiotechnol. 21(1), 445 (2023).
doi: 10.1186/s12951-023-02193-7
Lian, M. Q. et al. Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications. J. Extracell. Vesicles 11(12), e12283 (2022).
doi: 10.1002/jev2.12283 pubmed: 36519808
Chen, X. et al. Engineered plant-derived nanovesicles facilitate tumor therapy: Natural bioactivity plus drug controlled release platform. Int. J. Nanomed. 18, 4779–4804 (2023).
doi: 10.2147/IJN.S413831
Dad, H. A., Gu, T. W., Zhu, A. Q., Huang, L. Q. & Peng, L. H. Plant exosome-like nanovesicles: Emerging therapeutics and drug delivery nanoplatforms. Mol. Ther. J. Am. Soc. Gene Ther. 29(1), 13–31 (2021).
doi: 10.1016/j.ymthe.2020.11.030
Görgens, A. et al. Identification of storage conditions stabilizing extracellular vesicles preparations. J. Extracell. Vesicles 11(6), e12238 (2022).
doi: 10.1002/jev2.12238 pubmed: 35716060 pmcid: 9206228
Chen, Q. et al. Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharm. Sin. B 12(2), 907–923 (2022).
doi: 10.1016/j.apsb.2021.08.016 pubmed: 35256954
Ou, X. et al. Novel plant-derived exosome-like nanovesicles from Catharanthus roseus: Preparation, characterization, and immunostimulatory effect via TNF-α/NF-κB/PU.1 axis. J. Nanobiotechnol. 21(1), 160 (2023).
doi: 10.1186/s12951-023-01919-x
Zeng, L. et al. Codelivery of π-π stacked dual anticancer drugs based on aloe-derived nanovesicles for breast cancer therapy. ACS Appl. Mater. Interfaces 14(24), 27686–27702 (2022).
doi: 10.1021/acsami.2c06546 pubmed: 35675505
Hwang, J. H. et al. Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice. J. Control. Release 355, 184–198 (2023).
doi: 10.1016/j.jconrel.2023.01.071 pubmed: 36736431
Kilasoniya, A., Garaeva, L., Shtam, T., Spitsyna, A., Putevich, E., Moreno-Chamba, B., Salazar-Bermeo, J., Komarova, E., Malek, A., Valero, M. & Saura, D. Potential of Plant Exosome Vesicles from Grapefruit (Citrus × paradisi) and Tomato (Solanum lycopersicum) Juices as Functional Ingredients and Targeted Drug Delivery Vehicles. Antioxidants (Basel, Switzerland), 12(4) (2023).
Kim, K., Park, J., Sohn, Y., Oh, C. E., Park, J. H., Yuk, J. M. & Yeon, J. H. Stability of plant leaf-derived extracellular vesicles according to preservative and storage temperature. Pharmaceutics, 14(2) (2022).
Leng, Y., Yang, L., Zhu, H., Li, D., Pan, S. & Yuan, F. Stability of blueberry extracellular vesicles and their gene regulation effects in intestinal Caco-2 cells. Biomolecules, 13(9) (2023).
Yuan, H., Yang, M., Han, X. & Ni, X. The Therapeutic Effect of the Chinese Herbal Medicine, Rehmanniae Radix Preparata, in Attention Deficit Hyperactivity Disorder via Reversal of Structural Abnormalities in the Cortex. Evid. Based Complem. Altern. Med. eCAM 2018, 3052058 (2018).
doi: 10.1155/2018/3052058
Zhang, R. X., Li, M. X. & Jia, Z. P. Rehmannia glutinosa: Review of botany, chemistry and pharmacology. J. Ethnopharmacol. 117(2), 199–214 (2008).
doi: 10.1016/j.jep.2008.02.018 pubmed: 18407446
Bian, Z. et al. Extraction, structure and bioactivities of polysaccharides from Rehmannia glutinosa: A review. J. Ethnopharmacol. 305, 116132 (2023).
doi: 10.1016/j.jep.2022.116132 pubmed: 36634722
Huang, Y. et al. PEGylated nano-Rehmannia glutinosa polysaccharide induces potent adaptive immunity against Bordetella bronchiseptica. Int. J. Biol. Macromol. 168, 507–517 (2021).
doi: 10.1016/j.ijbiomac.2020.12.044 pubmed: 33310103
Qiu, F. S. et al. Rgl-exomiR-7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis. Biomed. Pharmacother. Biomed. Pharmacother. 165, 115007 (2023).
doi: 10.1016/j.biopha.2023.115007 pubmed: 37327587
Gan, R. H. et al. Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion. Cell Cycle (Georgetown, Tex.) 17(2), 216–224 (2018).
doi: 10.1080/15384101.2017.1395534 pubmed: 29117785
Zeng, L. et al. Aloe derived nanovesicle as a functional carrier for indocyanine green encapsulation and phototherapy. J. Nanobiotechnol. 19(1), 439 (2021).
doi: 10.1186/s12951-021-01195-7
Kabelka, I. & Vácha, R. Advances in molecular understanding of α-helical membrane-active peptides. Acc. Chem. Res. 54(9), 2196–2204 (2021).
doi: 10.1021/acs.accounts.1c00047 pubmed: 33844916
Mu, N. et al. Plant-derived exosome-like nanovesicles: Current progress and prospects. Int. J. Nanomed. 18, 4987–5009 (2023).
doi: 10.2147/IJN.S420748
Ly, N. P., Han, H. S., Kim, M., Park, J. H. & Choi, K. Y. Plant-derived nanovesicles: Current understanding and applications for cancer therapy. Bioact. Mater. 22, 365–383 (2023).
pubmed: 36311046
Fu, C. et al. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J. Ethnopharmacol. 289, 115021 (2022).
doi: 10.1016/j.jep.2022.115021 pubmed: 35091012
Xu, L., Zhang, W., Zeng, L. & Jin, J. O. Rehmannia glutinosa polysaccharide induced an anti-cancer effect by activating natural killer cells. Int. J. Biol. Macromol. 105(Pt 1), 680–685 (2017).
doi: 10.1016/j.ijbiomac.2017.07.090 pubmed: 28716751
Liu, N. A. et al. Rehmannia glutinosa polysaccharide regulates bone marrow microenvironment via HIF-1α/NF-κB signaling pathway in aplastic anemia mice. Anais da Academia Brasileira de Ciencias 95(3), e20220672 (2023).
doi: 10.1590/0001-3765202320220672 pubmed: 37556607
Yan, G. et al. Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy. J. Control. Release Off. J. Control. Release Soc. 367, 425–440 (2024).
doi: 10.1016/j.jconrel.2024.01.060
Sousa de Almeida, M. et al. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem. Soc. Rev. 50(9), 5397–5434 (2021).
doi: 10.1039/D0CS01127D pubmed: 33666625 pmcid: 8111542
Trenkenschuh, E. et al. Enhancing the Stabilization potential of lyophilization for extracellular vesicles. Adv. Healthc. Mater. 11(5), e2100538 (2022).
doi: 10.1002/adhm.202100538 pubmed: 34310074
Yuan, F., Li, Y. M. & Wang, Z. Preserving extracellular vesicles for biomedical applications: Consideration of storage stability before and after isolation. Drug Deliv. 28(1), 1501–1509 (2021).
doi: 10.1080/10717544.2021.1951896 pubmed: 34259095 pmcid: 8281093
Frank, J. et al. Extracellular vesicles protect glucuronidase model enzymes during freeze-drying. Sci. Rep. 8(1), 12377 (2018).
doi: 10.1038/s41598-018-30786-y pubmed: 30120298 pmcid: 6098026
Bosch, S. et al. Trehalose prevents aggregation of exosomes and cryodamage. Sci. Rep. 6, 36162 (2016).
doi: 10.1038/srep36162 pubmed: 27824088 pmcid: 5099918
Kocholata, M., Prusova, M., Auer Malinska, H., Maly, J. & Janouskova, O. Comparison of two isolation methods of tobacco-derived extracellular vesicles, their characterization and uptake by plant and rat cells. Sci. Rep. 12(1), 19896 (2022).
doi: 10.1038/s41598-022-23961-9 pubmed: 36400817 pmcid: 9674704

Auteurs

Xiaohang Chen (X)

Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Department of Preventive Dentistry, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.

Lianghang He (L)

Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Department of Preventive Dentistry, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.

Yao Chen (Y)

Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.

Genggeng Zheng (G)

Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Department of Preventive Dentistry, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.

Yating Su (Y)

Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
Department of Preventive Dentistry, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.

Yingcong Chen (Y)

Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.

Dali Zheng (D)

Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China. dalizheng@fjmu.edu.cn.

Youguang Lu (Y)

Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China. fjlyg63@fjmu.edu.cn.
Department of Preventive Dentistry, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China. fjlyg63@fjmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH